19-47480376-C-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_007059.4(KPTN):c.631G>C(p.Gly211Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00145 in 1,549,276 control chromosomes in the GnomAD database, including 24 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0077 ( 10 hom., cov: 30)
Exomes 𝑓: 0.00078 ( 14 hom. )
Consequence
KPTN
NM_007059.4 missense
NM_007059.4 missense
Scores
7
10
Clinical Significance
Conservation
PhyloP100: 3.01
Publications
0 publications found
Genes affected
KPTN (HGNC:6404): (kaptin, actin binding protein) This gene encodes a filamentous-actin-associated protein, which is involved in actin dynamics and plays an important role in neuromorphogenesis. This protein is part of the KICSTOR protein complex that localizes to lysosomes. Mutations in this gene result in an autosomal recessive form of intellectual disability. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jul 2017]
KPTN Gene-Disease associations (from GenCC):
- macrocephaly-developmental delay syndromeInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0056676865).
BP6
Variant 19-47480376-C-G is Benign according to our data. Variant chr19-47480376-C-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 435678.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0077 (1165/151204) while in subpopulation AFR AF = 0.027 (1109/41100). AF 95% confidence interval is 0.0257. There are 10 homozygotes in GnomAd4. There are 539 alleles in the male GnomAd4 subpopulation. Median coverage is 30. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 10 AR gene
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| KPTN | NM_007059.4 | c.631G>C | p.Gly211Arg | missense_variant | Exon 7 of 12 | ENST00000338134.8 | NP_008990.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| KPTN | ENST00000338134.8 | c.631G>C | p.Gly211Arg | missense_variant | Exon 7 of 12 | 1 | NM_007059.4 | ENSP00000337850.2 |
Frequencies
GnomAD3 genomes AF: 0.00770 AC: 1164AN: 151086Hom.: 10 Cov.: 30 show subpopulations
GnomAD3 genomes
AF:
AC:
1164
AN:
151086
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00174 AC: 265AN: 152372 AF XY: 0.00130 show subpopulations
GnomAD2 exomes
AF:
AC:
265
AN:
152372
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000777 AC: 1087AN: 1398072Hom.: 14 Cov.: 33 AF XY: 0.000669 AC XY: 461AN XY: 689544 show subpopulations
GnomAD4 exome
AF:
AC:
1087
AN:
1398072
Hom.:
Cov.:
33
AF XY:
AC XY:
461
AN XY:
689544
show subpopulations
African (AFR)
AF:
AC:
875
AN:
31578
American (AMR)
AF:
AC:
56
AN:
35610
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
25132
East Asian (EAS)
AF:
AC:
0
AN:
35720
South Asian (SAS)
AF:
AC:
3
AN:
79118
European-Finnish (FIN)
AF:
AC:
0
AN:
48778
Middle Eastern (MID)
AF:
AC:
3
AN:
5682
European-Non Finnish (NFE)
AF:
AC:
53
AN:
1078508
Other (OTH)
AF:
AC:
97
AN:
57946
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
50
100
149
199
249
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
30
60
90
120
150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00770 AC: 1165AN: 151204Hom.: 10 Cov.: 30 AF XY: 0.00730 AC XY: 539AN XY: 73866 show subpopulations
GnomAD4 genome
AF:
AC:
1165
AN:
151204
Hom.:
Cov.:
30
AF XY:
AC XY:
539
AN XY:
73866
show subpopulations
African (AFR)
AF:
AC:
1109
AN:
41100
American (AMR)
AF:
AC:
39
AN:
15188
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3470
East Asian (EAS)
AF:
AC:
0
AN:
5086
South Asian (SAS)
AF:
AC:
1
AN:
4766
European-Finnish (FIN)
AF:
AC:
0
AN:
10498
Middle Eastern (MID)
AF:
AC:
0
AN:
288
European-Non Finnish (NFE)
AF:
AC:
6
AN:
67806
Other (OTH)
AF:
AC:
10
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
46
93
139
186
232
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
63
ESP6500EA
AF:
AC:
2
ExAC
AF:
AC:
82
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
Aug 24, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
not specified Benign:1
Aug 08, 2016
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Macrocephaly-developmental delay syndrome Benign:1
Jan 26, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
DANN
Uncertain
DEOGEN2
Benign
T;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Benign
D
LIST_S2
Benign
T;T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;.
PhyloP100
PrimateAI
Uncertain
T
PROVEAN
Benign
N;.
REVEL
Benign
Sift
Uncertain
D;.
Sift4G
Uncertain
D;.
Vest4
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.